(Q27853297)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ivan Bieche

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Elisabetta Marangoni

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

6

Sophie Vacher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

8

Jean-Luc Servely

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sophie Chateau-Joubert

3

object named as

Sophie Château-Joubert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1

Rana Hatem

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Dalila Labiod

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ludmilla de Plater

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Florian Bonin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Véronique Dieras

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

6 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

2510-2521

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

Comprehensive molecular portraits of human breast tumours

3 March 2020

cites work

1 reference

RET in breast cancer: functional and therapeutic implications

21 January 2018

1 reference

Targeting RET receptor tyrosine kinase activation in cancer

21 January 2018

1 reference

Vandetanib, a novel multitargeted kinase inhibitor, in cancer therapy

21 January 2018

1 reference

Vandetanib: first global approval.

21 January 2018

1 reference

A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer

21 January 2018

1 reference

Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer

21 January 2018

1 reference

Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.

21 January 2018

1 reference

Ret inhibition decreases growth and metastatic potential of estrogen receptor positive breast cancer cells

21 January 2018

1 reference

Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: evidence that PKCι/λ overexpression is an independent prognostic factor.

21 January 2018

1 reference

Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

21 January 2018

1 reference

A new model of patient tumor-derived breast cancer xenografts for preclinical assays

21 January 2018

1 reference

Inhibiting aurora kinases reduces tumor growth and suppresses tumor recurrence after chemotherapy in patient-derived triple-negative breast cancer xenografts

21 January 2018

1 reference

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings

21 January 2018

1 reference

A quantitative analysis of kinase inhibitor selectivity

21 January 2018

1 reference

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

21 January 2018

1 reference

MAPK-regulated transcription: a continuously variable gene switch?

21 January 2018

1 reference

The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer

21 January 2018

1 reference

Vandetanib for the treatment of medullary thyroid cancer

21 January 2018

1 reference

Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.

21 January 2018

1 reference

RET revisited: expanding the oncogenic portfolio

21 January 2018

1 reference

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.

21 January 2018

1 reference

Vandetanib improves anti-tumor effects of L19mTNFalpha in xenograft models of esophageal cancer

21 January 2018

1 reference

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

ZD6474 induces growth arrest and apoptosis of GIST-T1 cells, which is enhanced by concomitant use of sunitinib

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.29974

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4757513

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26686064%20AND%20SRC:MED&resulttype=core&format=json

OpenCitations bibliographic resource ID

3 March 2020

4757513

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

13 November 2016